Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07575243
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut UniversityCompleted
NCT07575243Completed
—
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut University
NCT07576179
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises Comparative Effect in DPNRiphah International UniversityRecruitingNot Applicable
NCT07576179Recruiting
Not Applicable
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises C...Riphah International Univ...
NCT07576049
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La SapienzaEnrolling By Invitation
NCT07576049Enrolling By Invitation
—
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La Sap...
NCT07574957
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNAAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07574957Not Yet Recruiting
—
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of...Assistance Publique - Hôp...
NCT07574853
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodontal Bone Tissue RegenerationThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574853Not Yet Recruiting
Not Applicable
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodont...The First Affiliated Hosp...
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07575841
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fundación AlcorcónNot Yet RecruitingNot Applicable
NCT07575841Not Yet Recruiting
Not Applicable
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fu...
NCT07576387
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare HamiltonNot Yet RecruitingNot Applicable
NCT07576387Not Yet Recruiting
Not Applicable
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare H...
NCT07575516
Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneHasanuddin UniversityCompletedPhase 2
NCT07575516Completed
Phase 2
Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneHasanuddin University
NCT07574970
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS - A PILOT RCT IN INDIAN POPULATIONAsian Institute of Gastroenterology, IndiaRecruiting
NCT07574970Recruiting
—
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFT...Asian Institute of Gastro...
NCT07574515
The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Randomized Controlled TrialLinkoeping UniversityNot Yet RecruitingNot Applicable
NCT07574515Not Yet Recruiting
Not Applicable
The Effect of Nasogastric Tube Placement on Complications in Patients With Small...Linkoeping University
NCT07575906
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.PfizerNot Yet RecruitingPhase 1
NCT07575906Not Yet Recruiting
Phase 1
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is T...Pfizer
NCT07575373
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Intervention to Improve Transitions to Follow-Up Care for Hospitalized Patients With Substance Use DisordersMichael InczeNot Yet RecruitingNot Applicable
NCT07575373Not Yet Recruiting
Not Applicable
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Interventi...Michael Incze
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07574658
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample: a Study Protocol of a Randomized Clinical TrialUniversity of Sao PauloNot Yet RecruitingPhase 3
NCT07574658Not Yet Recruiting
Phase 3
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample:...University of Sao Paulo
NCT07575750
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA): a Phase 2, Randomized, Monocentric, taVNS Versus Sham, Double BlindInstitut Cancerologie de l'OuestNot Yet RecruitingNot Applicable
NCT07575750Not Yet Recruiting
Not Applicable
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatas...Institut Cancerologie de...
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
Result Breakdown
Not yet recruiting13 (65%)
Recruiting3 (15%)
Completed2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 14 (20%)
Phase 21 (5%)
Phase 31 (5%)